Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...

I think some respected newspapers could do a better job of being honest with their readers about some pretty basic and pretty important things.

The new "XEC" COVID-19 variant spreading rapidly in Europe has arrived in the US. What are the symptoms, will it cause a fall ...

What are the new XEC COVID variant symptoms, and when will it hit the U.S.? Doctors explain what to watch for, and the best ...

The new and contagious XEC COVID-19 variant is spreading rapidly in several countries. Will it cause a surge in the U.S.?

The new Covid variants are here, and as cold and flu season coincides with a busy travel season, here's what both Covid ...

A newly discovered COVID strain known as XEC continues to spread rapidly worldwide and in the U.S. Here's what to know about ...

With the U.S. Food and Drug Administration and Centers for Disease Control and Prevention approval of new mRNA COVID-19 ...

A new Covid variant, dubbed XEC, is spreading through Europe and could soon become the most dominant strain of the infection, ...